Lexeo Team
Lexeo’s management team consists of pioneers and driven leaders with decades of development experience in gene therapy and rare diseases.
Management Team

CHIEF EXECUTIVE OFFICER
R. Nolan Townsend

Chief Medical Officer and Head of Research
Eric Adler, MD

Chief Technical Officer
José Manuel Otero, PhD

Chief Financial Officer
Kyle Rasbach, PhD

Chief Legal Officer
Jenny R. Robertson

Chief Development Officer
Sandi See Tai, MD

Vice President, Clinical Operations
Julie Allen

Vice President, Discovery Research and Translation
Ranjan Batra, PhD

Vice President, Corporate Development
Jordan Baumhardt, PhD

Senior Vice President, Development Operations
Leslie DiRisio

Vice President, Analytical Development and Quality Control
Timothy Fenn, PhD

Vice President, Business Development
Morgan Jones

Vice President, Non-clinical and Bioanalytical Development
Richie Khanna, PhD

Vice President, Corporate Controller
Ryan McHenry

Vice President, Finance
Rand Monaghan

VICE PRESIDENT, PEOPLE EXPERIENCE
Jenny Speer

Vice President, Regulatory Affairs
Keith Wonnacott, PhD

FOUNDER & CHIEF SCIENTIFIC ADVISER
Ronald Crystal, MD

Senior Advisor
Rajiv Patni, MD